Tracey McCain
Compliance Officer chez BLUEPRINT MEDICINES CORPORATION
Fortune : 6 M $ au 31/03/2024
Profil
Tracey L.
McCain is an Independent Director at Kiniksa Pharmaceuticals Ltd.
and Secretary, Chief Legal & Compliance Officer at Blueprint Medicines Corp.
She was previously a General Counsel at Genzyme Corp.
and a Senior Vice President & Head-Legal at Genzyme Therapeutics Ltd.
She also worked as an Associate at Palmer & Dodge LLP.
McCain received her undergraduate degree from the University of Pennsylvania and her graduate degree from Columbia Law School.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
07/03/2024 | 60 498 ( 0,10% ) | 6 M $ | 31/03/2024 | |
29/06/2023 | 5 000 ( 0,01% ) | 98 650 $ | 31/03/2024 |
Postes actifs de Tracey McCain
Sociétés | Poste | Début |
---|---|---|
BLUEPRINT MEDICINES CORPORATION | Compliance Officer | 06/09/2016 |
KINIKSA PHARMACEUTICALS, LTD. | Director/Board Member | 01/02/2018 |
Anciens postes connus de Tracey McCain
Sociétés | Poste | Fin |
---|---|---|
IMMUNOGEN, INC. | Director/Board Member | 12/02/2024 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | General Counsel | 02/09/2016 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01/09/2016 |
Palmer & Dodge LLP | Corporate Officer/Principal | - |
Formation de Tracey McCain
University of Pennsylvania | Undergraduate Degree |
Columbia Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
IMMUNOGEN, INC. | Health Technology |
BLUEPRINT MEDICINES CORPORATION | Health Technology |
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
Entreprise privées | 3 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Palmer & Dodge LLP | Commercial Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |